Greenland et al. showed that the human NAD+-dependent 15-PGDH gene promoter is controlled through the transcription factors ETS and AP-1 in a number of different cell types of uterine, placental, and hematopoietic cancers [32]. This evidence concerns the gene JUN and hematopoietic and lymphoid cell neoplasm.